Archives of Digestive Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518081136

Perspective - Archives of Digestive Disorders (2025) Volume 7, Issue 1

The gut-brain axis: Microbes, mind, medicine

Jean Wang*

Department of Translational Research, Washington University, USA

*Corresponding Author:
Jean Wang
Department of Translational Research
Washington University, USA.
E-mail: jeanwg@wustl.edu

Received : 08-Jan-2025, Manuscript No. AAADD-25-188; Editor assigned : 10-Jan-2025, PreQC No. AAADD-25-188(PQ); Reviewed : 30-Jan-2025, QC No AAADD-25-188; Revised : 10-Feb-2025, Manuscript No. AAADD-25-188(R); Published : 19-Feb-2025 , DOI : 10.35841/ aaadd-7.1.188

Citation: Wang J. The gut-brain axis: Microbes, mind, medicin. Arch Dig Disord. 2025;07(01):188.

Visit for more related articles at Archives of Digestive Disorders

Introduction

This review distills the current understanding of the gut-brain axis, highlighting its bidirectional communication pathways involving neural, endocrine, immune, and metabolic signaling. It emphasizes the critical role of the gut microbiome in shaping brain function and behavior, influencing conditions like anxiety, depression, and neurodegenerative disorders. The article also points towards emerging therapeutic strategies targeting this axis [1].

This paper explores the gut-brain axis as a promising therapeutic target for psychiatric disorders. It reviews evidence linking gut microbiota dysbiosis to mental health conditions, discussing how microbial metabolites, immune modulation, and vagal nerve signaling contribute to brain function. The authors consider the potential of probiotics, prebiotics, and fecal microbiota transplantation in psychiatric treatment [2].

This article delves into the intricate relationship between the gut microbiota and neurodegenerative diseases, such as Alzheimer's and Parkinson's. It discusses how dysbiosis in the gut can lead to increased gut permeability, systemic inflammation, and the production of neurotoxic metabolites, all contributing to the progression of neurodegeneration. The authors highlight the potential for microbiota-targeted therapies [3].

This systematic review evaluates the therapeutic potential of prebiotics and probiotics in improving mental health, specifically anxiety and depression, through their influence on the gut-brain axis. The findings suggest that certain probiotic strains and prebiotics can modulate gut microbiota composition and function, leading to positive effects on mood and anxiety symptoms, although further robust clinical trials are needed [4].

This review highlights the critical interplay between the gut microbiota, brain immunity, and neuroinflammation. It explains how gut dysbiosis can disrupt the gut barrier, leading to the translocation of microbial products and systemic inflammation, which then primes microglia and exacerbates neuroinflammatory processes, contributing to various neurological and psychiatric conditions [5].

This systematic review explores the complex interplay between the gut microbiota and stress-related disorders. It consolidates evidence suggesting that alterations in gut microbial composition and function can profoundly influence the host's stress response, modulating neuroendocrine pathways, inflammatory processes, and neurotransmitter systems, offering new insights into therapeutic interventions [6].

This paper explores the involvement of the gut microbiota-brain axis in Autism Spectrum Disorder (ASD). It details how microbial dysbiosis, gut permeability, and microbial metabolites can influence neurodevelopment, immune function, and behavior in individuals with ASD, paving the way for potential microbiota-targeted interventions to alleviate ASD symptoms [7].

This updated review focuses on Short-Chain Fatty Acids (SCFAs) as key mediators of the gut-brain axis. It discusses how SCFAs, produced by gut bacteria, can cross the blood-brain barrier and exert direct effects on brain function, including neurotransmission, neuroinflammation, and neurogenesis, offering insights into their therapeutic potential for neurological and psychiatric conditions [8].

This review examines the profound impact of the gut microbiota-brain axis on neurodevelopmental disorders during early life. It details how early-life microbial colonization and subsequent dysbiosis can influence brain maturation, immune programming, and susceptibility to conditions like ASD and Attention Deficit Hyperactivity Disorder (ADHD), suggesting that targeting the gut microbiota during critical developmental windows might offer preventative or therapeutic opportunities [9].

This article focuses on the vagus nerve as a crucial anatomical and functional link within the microbiota-gut-brain axis. It elucidates how the vagus nerve transmits signals from the gut to the brain, mediating the effects of microbial metabolites and immune signals on mood, cognition, and stress responses, proposing vagal nerve modulation as a potential therapeutic strategy [10].

 

Conclusion

The gut-brain axis represents a vital, bidirectional communication system that profoundly influences human health and disease. This axis involves complex interactions between the gut microbiome, neural, endocrine, immune, and metabolic pathways. Current understanding emphasizes the microbiome's critical role in shaping brain function and behavior, affecting conditions from anxiety and depression to neurodegenerative diseases like Alzheimer's and Parkinson's. Dysbiosis in the gut microbiome is consistently linked to various neurological and psychiatric disorders, contributing to systemic inflammation, gut permeability issues, and the production of neurotoxic metabolites. The impact extends to neurodevelopmental disorders like Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder, particularly when microbial colonization and balance are altered during early life. Key mediators in this axis include Short-Chain Fatty Acids, which directly influence brain function, and the Vagus Nerve, acting as a crucial communication pathway. Therapeutic strategies targeting the gut microbiota, such as probiotics, prebiotics, and Fecal Microbiota Transplantation, are emerging as promising interventions for mental health conditions, stress-related disorders, and neurodegenerative diseases. Continued research highlights the potential for modulating the gut-brain axis to prevent and treat a wide range of brain-related conditions.

References

    1. Emeran AM, Kirsten N, Susan C. The Gut-Brain Axis. Annu Rev Med. 2022;73:439-453.

Indexed at, Google Scholar, Crossref

    1. Christina S, Manfred A, Thomas CB. The microbiota-gut-brain axis: an emerging target for psychiatric treatment?. Psychopharmacology (Berl). 2020;237(10):2991-3004.

Indexed at, Google Scholar, Crossref

    1. Yafei W, Hong W, Jingjing W. Gut microbiota-brain axis: A critical player in neurodegenerative diseases. Brain Behav Immun Health. 2021;12:100201.

Indexed at, Google Scholar, Crossref

    1. Matthew IB, Sabrina M, Kiran S. The Gut Microbiome and Mental Health: A Systematic Review of Prebiotics and Probiotics in Anxiety and Depression. Clin Nutr ESPEN. 2020;35:36-47.

Indexed at, Google Scholar, Crossref

    1. Ioana M, Roberta G, Michael M. Gut Microbiota and Its Effect on Brain Immunity and Neuroinflammation: A Narrative Review. Neuropsychiatr Dis Treat. 2020;16:3059-3074.

Indexed at, Google Scholar, Crossref

    1. Michela C, Elena S, Chiara C. Gut microbiota and stress-related disorders: a systematic review. World J Psychiatry. 2021;11(12):1276-1296.

Indexed at, Google Scholar, Crossref

    1. Yuanyuan L, Yang Z, Yan D. Gut microbiota-brain axis in autism spectrum disorder: from mechanisms to therapeutic opportunities. Transl Psychiatry. 2021;11(1):50.

Indexed at, Google Scholar, Crossref

    1. Jie L, Xu C, Juan Q. Short-chain fatty acids (SCFAs) as mediators of the gut-brain axis: an updated review. J Neuroinflammation. 2022;19(1):76.

Indexed at, Google Scholar, Crossref

    1. Yoona L, Jihyun S, Hyejung K. The Gut Microbiota-Brain Axis and Neurodevelopmental Disorders in Early Life: Focus on the Etiopathogenesis and Potential Therapeutic Strategies. Int J Mol Sci. 2021;22(16):8833.

Indexed at, Google Scholar, Crossref

    1. Francesca G, Orsola S, Erica F. The Vagus Nerve: A Gateway between the Gut Microbiota and the Central Nervous System. Int J Mol Sci. 2021;22(11):5800.

Indexed at, Google Scholar, Crossref

Get the App